Eckert & Ziegler Strahlen und Medizintechnik AG

24.10.2014 – 13:24
Eckert & Ziegler awarded contract to produce new type of medicine to fight pancreatic cancer
Berlin (ots) - Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is engaging with a USA based biotech company to become a contract manufacturer for a new type of cancer treatment and is creating a new production plant for this purpose at its Braunschweig location with financial support provided by the customer. The cooperation enfolds a brand-new ...
mehr
10.09.2012 – 14:00
Eckert & Ziegler acquires Vitalea Science Inc. as Part of Strategic Move into Innovative Pharmaceutical Services
Berlin (ots) - Eckert & Ziegler Strahlen- und Medizintechnik AG, through its Californian subsidiary Eckert & Ziegler Isotope Products, Inc. (EZIP), has entered into a definite agreement with Vitalea Science, Inc. for the purchase of all of its stock and assets. Vitalea Science is a pioneering Bioanalytical Contract ...
mehr